oxymatrine has been researched along with Stomach Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, BJ; Kim, H; Kim, JN; Kim, JS; Kim, YT; Kwon, MJ; Lim, EY; Shin, SJ | 1 |
| Guo, B; Li, X; Su, J; Wang, K; Zhang, T | 1 |
| Chen, JL; Da, W; Song, MQ; Wang, L; Zhang, WP; Zhu, JS; Zhu, L | 1 |
3 other study(ies) available for oxymatrine and Stomach Neoplasms
| Article | Year |
|---|---|
Radix Sophorae Flavescentis inhibits proliferation and induces apoptosis of AGS human gastric cancer cells.
Topics: Alkaloids; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drugs, Chinese Herbal; Humans; MAP Kinase Signaling System; Matrines; Mitochondria; Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-bcl-2; Quinolizines; Reactive Oxygen Species; Stomach Neoplasms | 2019 |
Oxymatrine targets EGFR(p-Tyr845) and inhibits EGFR-related signaling pathways to suppress the proliferation and invasion of gastric cancer cells.
Topics: Alkaloids; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; ErbB Receptors; G1 Phase; Humans; Membrane Potential, Mitochondrial; Neoplasm Invasiveness; Phosphorylation; Quinolizines; Signal Transduction; Stomach Neoplasms; Tyrosine | 2015 |
Synergistic effect of oxymatrine and angiogenesis inhibitor NM-3 on modulating apoptosis in human gastric cancer cells.
Topics: Alkaloids; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Apoptosis Proteins; Isocoumarins; Mice; Mice, Nude; Microtubule-Associated Proteins; Neoplasm Proteins; Proto-Oncogene Proteins c-bcl-2; Quinolizines; RNA, Messenger; Stomach Neoplasms; Survivin; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2007 |